A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
NCT00903565
·
clinicaltrials.gov ↗
UNKNOWN
Status
1200
Enrollment
INDUSTRY
Sponsor class
Conditions
Colon Cancer
Sponsor
Agendia